Precision Therapeutics raises $33 million in Series D financing

06/14/2010 | American City Business Journals

Precision Therapeutics secured $33 million in a Series D funding round, led by venture capital firm Bain Capital. Precision will use the proceeds to boost the growth of ChemoFx, a technology that helps identify a type of chemotherapy that is likely to benefit an individual cancer patient, and develop genomics-based products.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Systems Test - V&V Engineer - 14000008LS
Abbott
San Jose, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC